• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期前肠神经内分泌肿瘤的内镜治疗

Endoscopic treatment for early foregut neuroendocrine tumors.

作者信息

Park Moo In

机构信息

Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.

出版信息

Clin Endosc. 2013 Sep;46(5):450-5. doi: 10.5946/ce.2013.46.5.450. Epub 2013 Sep 30.

DOI:10.5946/ce.2013.46.5.450
PMID:24143301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3797924/
Abstract

Foregut neuroendocrine tumors (NETs) include those arising in the esophagus, stomach, pancreas, and duodenum and seem to have a broad range of clinical behavior from benign to metastatic. Several factors including the advent of screening endoscopy may be related to increased incidence of gastrointestinal NETs; thus, many foregut NETs are diagnosed at an early stage. Early foregut NETs, such as those of the stomach and duodenum, can be managed with endoscopic treatment because of a low frequency of lymph node and distant metastases. However, controversy continues concerning the optimal management of early foregut NETs due to a lack of controlled prospective studies. Several issues such as indications, technical issues, and outcomes of endoscopic treatment for early foregut NETs are reviewed based on some published studies.

摘要

前肠神经内分泌肿瘤(NETs)包括起源于食管、胃、胰腺和十二指肠的肿瘤,其临床行为似乎具有从良性到转移性的广泛范围。包括筛查内镜检查的出现在内的几个因素可能与胃肠道NETs发病率增加有关;因此,许多前肠NETs在早期被诊断出来。早期前肠NETs,如胃和十二指肠的NETs,由于淋巴结转移和远处转移的频率较低,可以通过内镜治疗进行处理。然而,由于缺乏对照前瞻性研究,关于早期前肠NETs的最佳治疗仍存在争议。基于一些已发表的研究,对早期前肠NETs内镜治疗的适应症、技术问题和结果等几个问题进行了综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e01/3797924/c95660bcf677/ce-46-450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e01/3797924/c95660bcf677/ce-46-450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e01/3797924/c95660bcf677/ce-46-450-g001.jpg

相似文献

1
Endoscopic treatment for early foregut neuroendocrine tumors.早期前肠神经内分泌肿瘤的内镜治疗
Clin Endosc. 2013 Sep;46(5):450-5. doi: 10.5946/ce.2013.46.5.450. Epub 2013 Sep 30.
2
Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.内镜黏膜下剥离术治疗上消化道神经内分泌肿瘤:初步研究。
World J Gastroenterol. 2012 Oct 28;18(40):5799-806. doi: 10.3748/wjg.v18.i40.5799.
3
Endosonography of neuroendocrine tumors of the stomach, duodenum, and pancreas.胃、十二指肠和胰腺神经内分泌肿瘤的内镜超声检查
Ann N Y Acad Sci. 1994 Sep 15;733:425-36. doi: 10.1111/j.1749-6632.1994.tb17292.x.
4
[Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum].[食管、胃和十二指肠神经内分泌肿瘤患者的管理]
Nihon Geka Gakkai Zasshi. 2008 May;109(3):147-51.
5
Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.前肠神经内分泌肿瘤内镜及手术切除的长期预后
J Dig Dis. 2015 Oct;16(10):595-600. doi: 10.1111/1751-2980.12279.
6
PCSK2 can be Useful in a Panel Approach to Distinguish Foregut and Midgut Neuroendocrine Tumors.在区分前肠和中肠神经内分泌肿瘤的综合方法中,PCSK2可能会有所帮助。
Int J Surg Pathol. 2025 Feb;33(1):76-84. doi: 10.1177/10668969241260208. Epub 2024 Jul 21.
7
Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.十二指肠第二部神经内分泌肿瘤的外科治疗:单中心经验及文献系统综述
Langenbecks Arch Surg. 2017 Sep;402(6):925-933. doi: 10.1007/s00423-016-1537-6. Epub 2016 Dec 3.
8
Surgical treatment for gastrointestinal neuroendocrine tumors.胃肠道神经内分泌肿瘤的外科治疗
Ann Gastroenterol Surg. 2020 Sep 12;4(6):652-659. doi: 10.1002/ags3.12396. eCollection 2020 Nov.
9
Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.内镜黏膜下剥离术治疗胃肠道神经内分泌肿瘤的疗效及安全性:中国北方地区10年数据分析
Scand J Gastroenterol. 2019 Mar;54(3):384-389. doi: 10.1080/00365521.2019.1588367. Epub 2019 Apr 30.
10
Management of early gastrointestinal neuroendocrine neoplasms.早期胃肠道神经内分泌肿瘤的管理
World J Gastrointest Endosc. 2011 Jul 16;3(7):133-9. doi: 10.4253/wjge.v3.i7.133.

引用本文的文献

1
Efficacy and safety of Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.Lu-DOTATATE 在晚期胰腺神经内分泌肿瘤患者中的疗效和安全性:来自 NETTER-R 国际回顾性研究的数据。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3529-3537. doi: 10.1007/s00259-022-05771-3. Epub 2022 Apr 7.
2
Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.食管神经内分泌癌人群的发病率、治疗及生存分析
Transl Cancer Res. 2020 Jul;9(7):4317-4329. doi: 10.21037/tcr-19-2650.
3
Gastric Neuroendocrine Tumor Mimicking Gastrointestinal Stromal Tumor: A Case Report.

本文引用的文献

1
The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.台湾神经内分泌肿瘤的流行病学:基于全国癌症登记的研究。
PLoS One. 2013 Apr 22;8(4):e62487. doi: 10.1371/journal.pone.0062487. Print 2013.
2
Current concepts on gastric carcinoid tumors.目前关于胃类癌肿瘤的概念。
Gastroenterol Res Pract. 2012;2012:287825. doi: 10.1155/2012/287825. Epub 2012 Dec 17.
3
Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.内镜黏膜下剥离术治疗上消化道神经内分泌肿瘤:初步研究。
酷似胃肠道间质瘤的胃神经内分泌肿瘤:一例报告
Case Rep Oncol. 2021 Sep 6;14(3):1271-1276. doi: 10.1159/000518078. eCollection 2021 Sep-Dec.
4
Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对接受切除术的中肠神经内分泌肿瘤患者的预后作用。
Int J Colorectal Dis. 2019 Nov;34(11):1849-1856. doi: 10.1007/s00384-019-03356-5. Epub 2019 Sep 13.
5
Metastatic neuroendocrine tumor of the esophagus with features of medullary thyroid carcinoma.具有甲状腺髓样癌特征的食管转移性神经内分泌肿瘤。
Intractable Rare Dis Res. 2017 Aug;6(3):224-229. doi: 10.5582/irdr.2017.01035.
6
Correlation of Ki-67 indices from biopsy and resection specimens of neuroendocrine tumours.神经内分泌肿瘤活检与切除标本中Ki-67指数的相关性
Ann R Coll Surg Engl. 2017 Mar;99(3):193-197. doi: 10.1308/rcsann.2016.0225. Epub 2016 Aug 4.
7
Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection.食管神经内分泌癌:49例手术切除病例的临床特征及预后评估
J Thorac Dis. 2016 Jun;8(6):1250-6. doi: 10.21037/jtd.2016.04.21.
8
[Surgical approach of gastroduodenal neuroendocrine neoplasms].[胃十二指肠神经内分泌肿瘤的手术治疗方法]
Chirurg. 2016 Apr;87(4):280-7. doi: 10.1007/s00104-015-0138-1.
9
Small cell neuroendocrine carcinoma of the esophagus.食管小细胞神经内分泌癌
Kaohsiung J Med Sci. 2015 Feb;31(2):108-9. doi: 10.1016/j.kjms.2014.11.007. Epub 2014 Dec 13.
World J Gastroenterol. 2012 Oct 28;18(40):5799-806. doi: 10.3748/wjg.v18.i40.5799.
4
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).胃肠胰神经内分泌(包括类癌)肿瘤(NETs)管理指南。
Gut. 2012 Jan;61(1):6-32. doi: 10.1136/gutjnl-2011-300831. Epub 2011 Nov 3.
5
Management of early gastrointestinal neuroendocrine neoplasms.早期胃肠道神经内分泌肿瘤的管理
World J Gastrointest Endosc. 2011 Jul 16;3(7):133-9. doi: 10.4253/wjge.v3.i7.133.
6
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate.Ⅰ型胃神经内分泌肿瘤:内镜治疗与复发率的前瞻性研究。
Neuroendocrinology. 2012;95(3):207-13. doi: 10.1159/000329043. Epub 2011 Jul 30.
7
Endoscopic resection of duodenal bulb neuroendocrine tumor larger than 10 mm in diameter.内镜下切除直径大于 10mm 的十二指肠球部神经内分泌瘤。
BMC Gastroenterol. 2011 Jun 10;11:67. doi: 10.1186/1471-230X-11-67.
8
Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor.I 型胃类癌的发病机制、诊断和治疗的研究进展。
World J Surg. 2011 Aug;35(8):1879-86. doi: 10.1007/s00268-011-1137-0.
9
Carcinoid tumors of the duodenum and the ampulla of Vater: current diagnostic and therapeutic approach in a series of 8 patients. Case series.十二指肠和 Vater 壶腹类癌肿瘤:8 例患者系列中的当前诊断和治疗方法。病例系列。
Int J Surg. 2011;9(3):248-53. doi: 10.1016/j.ijsu.2010.12.003. Epub 2011 Jan 5.
10
Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management.小肠神经内分泌肿瘤的发病率呈上升趋势:早期情况与治疗
World J Gastrointest Endosc. 2010 Oct 16;2(10):325-34. doi: 10.4253/wjge.v2.i10.325.